Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05196191 · ClinicalTrials.gov registry record · NA
Wound Healing Following Penile Prosthesis Implant
A NA study, sponsored by VIVEX Biologics.
- Terminated
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT05196191 is a NA study that was terminated before completion, run by VIVEX Biologics. The registered enrollment target is 32 participants.
The verdict
NCT05196191, a NA study, was terminated before completion, sponsored by VIVEX Biologics.
- TERMINATED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
This is a prospective, randomized, clinical study aimed to evaluate the safety and efficacy of the two treatment schedules on men undergoing penile implant surgery for the first time. The patients are randomized in a 2:1 ratio of active to sham treatment groups.
Interventions
- BIOLOGICAL VIAGENEX Max
- PROCEDURE Hibiclens wash
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2022-01-03 |
| Est. Completion | 2023-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05196191
The ClinicalTrials.gov registry entry for NCT05196191 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VIVEX Biologics, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which VIAGENEX Max is the first listed.
NCT05196191 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05196191 about?
NCT05196191 is a clinical study titled "Wound Healing Following Penile Prosthesis Implant". This is a prospective, randomized, clinical study aimed to evaluate the safety and efficacy of the two treatment schedules on men undergoing penile implant surgery for the first time. The patients are randomized in a 2:1 ratio of active to sham treatment groups.
What is the current status of trial NCT05196191?
This trial is currently terminated. It is a NA study. The enrollment target is 32 participants. The study started on 2022-01-03. Estimated completion is 2023-12-30.
What interventions are being tested in trial NCT05196191?
The interventions under investigation include: VIAGENEX Max (BIOLOGICAL), Hibiclens wash (PROCEDURE).
Who is sponsoring clinical trial NCT05196191?
This trial is sponsored by VIVEX Biologics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.